Tag: Biomedical Advanced Research and Development Authority

BARDA to Support Altimmune Anthrax Vaccine Clinical Trials Under $120M ContractContract Awards

BARDA to Support Altimmune Anthrax Vaccine Clinical Trials Under $120M Contract

Altimmune has received a potential five-year, $120.2 million contract from the Biomedical Advanced Research and Development Authority to conduct clinical
Emergent BioSolutions Lands BARDA Task Order for Zika Vaccine DevelopmentContract Awards

Emergent BioSolutions Lands BARDA Task Order for Zika Vaccine Development

The Biomedical Advanced Research and Development Authority has awarded Emergent BioSolutions (NYSE: EBS) a potential $21.9 million task order to develop
CDC Awards Emergent BioSolutions New Anthrax Vaccine Development FundsContract Awards

CDC Awards Emergent BioSolutions New Anthrax Vaccine Development Funds

The Department of Health and Human Services has tapped Emergent BioSolutions to further develop a new anthrax vaccine under a 30-month, $31

The Ultimate Guide to Winning Government Contracts Let us show you how top executives are winning so you can replicate it